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ORIGINAL RESEARCH ARTICLE
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Abstract
Introduction: Hypogonadotropic hypogonadism (HH) is an almost universal, yet underappreciated, endocrinological complication of traumatic brain injury (TBI). The goal
of this study was to determine whether the developmental hormone human chorionic
gonadotropin (hCG) treatment could reverse HH induced by a TBI.
Methods: Plasma samples were collected at post-surgery/post-injury (PSD/PID) days -10,

3

1, 11, 19 and 29 from male Sprague-Dawley rats (5- to 6-month-old) that had undergone

4

severe CCI injury) and treatment with saline or hCG (400 IU/kg; i.m.) every other day.

Geriatric Research, Education and Clinical
Center, Veterans Administration Hospital,
Madison, WI, USA
School of Exercise, Biomedical and
Health Sciences, Edith Cowan University,
Joondalup, Australia

a Sham surgery (craniectomy alone) or CCI injury (craniectomy + bilateral moderate-to-
Results: Both Sham and CCI injury significantly decreased circulating testosterone
(T), 11-deoxycorticosterone (11-DOC) and corticosterone concentrations to a similar
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extent (79.1% vs. 80.0%; 46.6% vs. 48.4%; 56.2% vs. 32.5%; respectively) by PSD/
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poadrenalism following either procedure.

PID 1. hCG treatment  returned circulating T to baseline concentrations by PSD/PID
1 (8.9 ± 1.5 ng/ml and 8.3 ± 1.9 ng/ml; respectively) and was maintained through
PSD/PID 29. hCG treatment significantly, but transiently, increased circulating progesterone (P4) ~3-fold (30.2 ± 10.5 ng/ml and 24.2 ± 5.8 ng/ml) above that of baseline
concentrations on PSD 1 and PID 1, respectively. hCG treatment did not reverse hyConclusions: Together, these data indicate that (1) craniectomy is sufficient to induce
persistent hypogonadism and hypoadrenalism, (2) hCG can reverse hypogonadism induced by a craniectomy or craniectomy +CCI injury, suggesting that (3) craniectomy
and CCI injury induce a persistent hypogonadism by decreasing hypothalamic and/
or pituitary function rather than testicular function in male rats. The potential role
of hCG as a cheap, safe and readily available treatment for reversing surgery or TBI-
induced hypogonadism is discussed.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2021 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.
Endocrinol Diab Metab. 2021;4:e00239.
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I NTRO D U C TI O N

suppression of the HPG axis.43,44 While prevalence rates for HH vary
widely, likely due to the severity of the injury, location and type of

Traumatic brain injury (TBI) is a major public health problem1 due to

injury, time of screening and design of the study, there is increasing

the relatively high incidence rate (106 per 100,000 globally), 2 and

consensus that even mild TBIs can induce HH and that severe TBIs

the lack of effective treatments. The incidence of TBI in males is

induce persistent HH.6,14,45–47 This silent condition goes mostly undi-

3

3 times that of females, but normalizes to 1:1 by age 65. The con-

agnosed and therefore untreated. Based on the pleiotropic properties

sequences of a TBI can include functional (eg decreased cognitive

of hCG, in this study we tested whether hCG treatment could reverse

performance), psychopathological (eg post-traumatic stress disor-

HH induced by a commonly used TBI model (controlled cortical im-

der), neuroanatomical (eg cystic infarcts, neurodegeneration) and

pact; CCI). We find that hCG treatment reverses HH induced by either

biochemical (eg inflammation) changes.

a craniectomy alone, or a craniectomy and penetrating CCI injury, in

An underappreciated endocrinological complication of TBI is hy-

adult male rats.

pogonadotropic hypogonadism (HH). TBI can markedly suppress pituitary gonadotropin secretion and gonadal sex steroid production.4–16
Such hypothalamic-pituitary-gonadal (HPG) axis hormones have well-
described roles in the formation and maintenance of brain structure
and cognitive function (reviewed in Hara et al.17). Our early studies

2
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M ATE R I A L S A N D M E TH O DS

2.1 | Subjects

utilizing human embryonic stem cells (hESC) as a model of early embryogenesis18 identified human chorionic gonadotropin (hCG), a tro-

Male Sprague-Dawley rats (n = 58, 5 to 6 months old) were acquired

phoblastic gonadotropin hormone, as modulating the expression and

from Harlan Laboratories Inc. (Madison, WI) and acclimated to the en-

processing of the amyloid-β precursor protein (AβPP19,20). Although

vironment over 2 days. Rats were then weighed and handled for no less

this protein has well-defined neurogenic properties, 21–26 our data

than 5 min. each for 5 consecutive days and daily thereafter while being

suggested AβPP also had important developmental functions during

housed, fed and maintained on a 12-h reverse light/dark cycle. The

early human embryogenesis (prior to the formation of neural precur-

Institutional Animal Care and Use Committee (Animal Component of

sor cells). We subsequently determined that hCG signals via the lutein-

Research Protocol) at the William S. Middleton Veterans Administration

izing hormone/chorionic gonadotropin receptor (LHCGR) on hESC to

Hospital approved the procedures used in this study, and the research

promote the growth and development of the pre-implantation em-

was conducted in an AAALAC-approved facility. Experimenters were

bryo, including the formation of the 3 germ layers in the morula and

blinded as to the identity of the animals throughout injections, blood

its development into a blastocyst.27,28 hCG mediated these effects via

collections, and body weight and hormone data analyses.

the upregulation of steroidogenesis (P4 synthesis); P4 signalling was
found to be obligatory for both embryoid body (aka morula) and neuroectodermal rosette (aka primitive neural tube) formation.

2.2 | Surgeries

In addition to hCG's role in early embryonic and brain development, 27 hCG and its adult homolog luteinizing hormone (LH) promote

All surgical procedures were carried out under isoflurane gas anaes-

neuronal proliferation, 29 while hCG and sex steroids regulate adult

thesia (5% for induction; 1.5%–3.0% for maintenance, craniectomy

neuronal differentiation (ie neuritogenesis, spine density, synaptogen-

~15-  to 30-min duration; craniectomy +CCI injury ~25-  to 45-min

esis).30,31 Conversely, age-related or age-induced reproductive endo-

duration). An anaesthesia chamber was used for induction, and a

crine dyscrasia has a negative impact on cognitive function,32 an effect

nose cone was used for maintenance.

that can be slowed or halted by the partial rebalancing of the HPG
axis with sex steroid supplementation33,34 or gonadotropin-releasing
hormone (GnRH) superagonist and antagonist treatment.35 HH could
therefore greatly compromise cognitive performance and neurore-

2.2.1 | Controlled cortical impact and
sham surgeries

generation following a TBI. Importantly, hCG has been shown to improve functional recovery following spinal cord injury in rats,30,36,37

Anaesthetized rats were mounted in a Kopf stereotaxic device

and decrease ischaemic brain injury in adult and neonatal rodent

(Model 900), where the animal's head was held in place by non-

models of stroke.

38–4 0

Aside from these neuroprotectant properties,

hCG also promotes neurite sprouting and neuron survival.40

traumatic ear bars and a bite bar. Anaesthesia was maintained
by nose cone while the head was shaved and sterilized with 70%

TBI-induced HH is thought to result from damage to the hypo-

ethanol and Betadine™ (Purdue Products L.P.) antiseptic solution.

thalamus or pituitary41,42 and/or stress-induced cortisol-mediated

Throughout surgery, anaesthesia levels were monitored closely and

|
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were frequently adjusted as needed, based on heart rate, respiration
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2.4 | Blood collection and hormone analyses

rate and oxygen saturation. A homeothermic blanket control unit
(Harvard Apparatus, Holliston, MA) was used to monitor body temperature and to prevent hypothermia throughout surgery.
Under aseptic conditions, the cranium and its bony landmarks in-

Rats were anaesthetized (between 9:00 a.m.–12:00 noon) and their
tails placed in a 200-ml beaker filled with warm water (≤44°C) for
5 min. The tail was cleaned with 70% alcohol, the minimal amount

cluding bregma (β) and lambda (λ) were exposed by making a midline

of the tail tip snipped with a blade, and/or the wound reopened by

incision along the scalp into the skin and fascia covering the skull. A

removal of the scab for subsequent bleeds, and ~1 ml of whole blood

6-mm-diameter craniectomy was centred on the midline at 2.5 mm

was collected directly into EDTA tubes at baseline (post-injury day

anterior to β. The cortical impact was made at 2.5 mm anterior to β

(PID)−10) and at PID, 1, 11, 19 and 29. Blood collected did not exceed

over the midline of the medial frontal cortex with an Impact One™

1% of body weight every 2-week period. Animals were injected with

Stereotaxic CCI instrument (Leica), using a 5 mm impactor (bit size),

Lactate Ringers solution (5 ml) for fluid resuscitation. At the terminal

travelling at 2.25 m/s (velocity), extending 3 mm below the cortical

bleed (day 29), blood also was collected via heart puncture. Collected

surface (impact depth) for 100 ms (dwell time). Sham-injured groups

blood was immediately centrifuged at 4000 g for 10–20 min. and

received the same surgical procedures up to and including craniectomy

the plasma aliquoted into Eppendorf tubes for storage at −80°C.

but no CCI injury. After surgery, the rats were placed on a heating pad,

Plasma samples were analysed at the Assay Services Laboratory in

monitored closely and upon awakening were tested 30 min later for

the Wisconsin National Primate Research Center of the UW-Madison

righting reflex to assess any immediate effects of craniectomy or CCI

Institute for Clinical and Translational Research for progesterone (P4),

injury on righting ability, and then returned to their home cages.

testosterone (T), 11-deoxycorticosterone (11-DOC) and corticosterone adapted from a method previously described.48,49 Briefly, to

2.3 | Experimental design

plasma samples (400 μl) internal standard (200 pg d9-progesterone
and d5-testosterone and 1 ng d4-cortisol) was added and the samples were extracted with methyl tert butyl ether. The organic phase

Once out of quarantine all rats were weighed and handled for one

was transferred to a clean vial and evaporated to dryness, and then,

week. The final body weights at the end of this week were (1) ranked

a second dichloromethane extraction was performed. The organic

from highest to lowest (as a function of age) and then (2) used to

phase was transferred into a clean test tube and evaporated to dry-

assign each rat to a surgery/treatment group in a counterbalanced

ness and reconstituted in mobile phase. Samples were analysed on

manner (ie using the ABBA method).

a QTRAP 5500 quadruple linear ion trap mass spectrometer (AB
Sciex) equipped with an atmospheric pressure chemical ionization
source. The system includes two Shimadzu LC20ADXR pumps and a

2.3.1 | Experiment 1

Shimadzu SIL20ACXR autosampler. A sample of 30 μl was injected
onto a Phenomenex Kinetex 2.6u C18 100A, 100 × 2.1 mm column

Rats were assigned to the following groups: Sham + saline (n = 5),

(Torrance, CA) for separation using a mobile phase: water with 1%

Sham + hCG (n = 5), CCI + saline (n = 8), CCI + hCG (n = 8). Baseline

formic acid (Solution A) and acetonitrile with 1% formic acid (Solution

blood draws were collected from all animals. Beginning 1 hour after

B), at a flow rate of 200 μl/min. Quantitative results were recorded as

craniectomy or CCI, Pregnyl® (hCG, 400 IU/kg; Merck & Co., Inc.)

multiple reaction monitoring (MRM) area counts after determination

or saline (0.9% NaCl in deionized H2O; equivalent volume to that

for the response factor for each compound and internal standard. Each

injected for hCG) was injected intramuscularly every other day for

steroid had a MRM used for quantitation and 1 or 2 additional MRMs

29 days. Pregnyl® is a highly purified pyrogen-free preparation ob-

as qualifiers. The linearity was r > .818, and the curve fit was linear

tained from the urine of pregnant females. Each vial contains 10,000

with 1/x weighting. None of the compounds of interest were detected

USP units of sterile dried powder with 5 mg monobasic sodium

in blank or double blank samples. Inter-assay coefficients of variation

phosphate and 4.4 mg dibasic sodium phosphate that is diluted in

were determined from a pool of rat plasma: T—2.1%, P4—11.2%, 11-

solvent containing water, 0.56% sodium chloride and 0.9% benzyl

DOC—5.3%, corticosterone—8.0%, androstenedione—13.3%.

alcohol (https://www.drugs.com/pro/pregnyl.html).

2.3.2 | Experiment 2

2.5 | Statistical analysis
A mixed factorial analysis of variance (ANOVA) for repeated meas-

Rats were assigned to the following groups: Sham + saline + RU-486

ures was performed on the weight, behavioural, hormonal and gross

(n = 5), Sham + hCG + RU-486 (n = 5), CCI + saline + RU-486 (n = 5), or

lesion data (GraphPad Prism, v.7; GraphPad Software, Inc.). Post hoc

CCI + hCG + RU-486 (n = 5). RU-486 (Mifepristone, 100 mg/ml solu-

analyses were performed using the Tukey multiple comparison test.

tion, CAS Number 84371-65-3; 40 mg/kg in 100% ethanol; Sigma-

Independent paired t tests were also used to compare the differ-

Aldrich Corp.) was injected intraperitoneally 15–20 min before every

ences between baseline (pre-injury) and post-injury data when data

hCG or saline control injection.

were normally distributed. Hormone data collected on post-surgery

4 of 11
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(PSD) or post-injury (PID) days were analysed using the R statisti-

(56.2%; 218.7 ± 24.5 ng/ml to 95.9 ± 2.2 ng/ml, p < .05) by PSD1

cal program, V.3.4.1 (R: A language and environment for statistical

(Figure 1).52 Similar declines in circulating concentrations of T (80.0%,

computing (program), Vienna, Austria: R Foundation for Statistical

1.5 ± 0.4 ng/ml, p < .01), P4 (56.8%, 3.9 ± 1.4 ng/ml; p = .065), 11-

Computing, 2008), with package ‘rmcorr’ (rmcorr: repeated-

DOC (48.4%, 174.5 ± 19.4 ng/ml; p < .05) and corticosterone (32.5%,

measures correlation (program), R package version 0.2.0, 2017),

147.7 ± 17.4 ng/ml; p < .05) were observed by PID 1 for CCI-injured

based on Bland and Altman's

50,51

statistical technique. Non-repeated

animals (ie craniectomy + CCI + saline group), indicating that Sham

baseline data were analysed using Pearson's correlation with the R

surgery alone was sufficient to induce hypogonadotropic hypogo-

program. Statistical significance was established at p ≤ .05.

nadism (Figure 1A,B) and hypoadrenalism (Figure 1C,D).52 Circulating
concentrations for all hormones in both Sham surgery and CCI-injured

3

|

animals remained at these lower concentrations through PSD/PID

R E S U LT S

29 (except corticosterone in the CCI group on PID 29, which rose to
190.0 ± 33.0 ng/ml, Figure 1D). Circulating concentrations of andro-

3.1 | Craniectomy and controlled cortical impact
injury induce hypogonadism and hypoadrenalism

stenedione did not significantly change from baseline (0.58 ± 0.10 ng/
ml) in Sham surgery or CCI injury groups (data not shown). These results suggest that sham surgery, and sham surgery plus a bilateral

ANOVA indicated a significant main effect of treatment for T

moderate-to-severe CCI injury, induces hypogonadism in rats.

(F(3,82) = 14.35, p < .0001), P4 (F(3,80) = 11.34, p < .0001), 11-
DOC (F(3,88) = 9.27, p < .0001) and corticosterone (F(3,88) = 24.98,

3.2 | hCG reverses craniectomy and CCI-induced
hypogonadism and attenuates hypoadrenalism

p < .0001). A main effect of day was found for P4 (F(3,80) = 5.26,
p = .0023), but not for T (F(3,82) = 1.02, p = .386), 11-DOC
(F(3,88) = 1.31, p = .277) and corticosterone (F(3,88) = 0.91,
p = .440). No main effects of treatment × day interaction were found

hCG treatment of animals that underwent a craniectomy (Sham

for T (F(9,82) = 0.33, p = .964), P4 (F(9,80) = 1.74, p = .095), 11-DOC

surgery) or craniectomy plus CCI injury (CCI group) significantly

(F(9,88) = 1.07, p = .396) or corticosterone (F(9,88) = 0.94, p = .498).

increased circulating concentrations of T and P4 back to baseline

Sham surgery (craniectomy + saline group) in male adult rats

concentrations by PSD/PID 1 (Figure 1A,B). Unlike P4, elevations

induced a decline from baseline in the circulating concentrations

in T were maintained through PSD/PID 29. While a significant main

of T (79.1%; 7.5 ± 1.5 ng/ml to 1.6 ± 0.3 ng/ml; p < .05), P4 (61.6%;

effect of treatment group for androstenedione concentration also

9.0 ± 3.8 ng/ml to 3.5 ± 0.7 ng/ml; p = .061), 11-DOC (46.6%;

was identified, post hoc analyses determined that androstenedione

338.3 ± 55.8 ng/ml to 180.7 ± 3.3 ng/ml, p < .05) and corticosterone

concentration was only elevated on PID 11 in the CCI +hCG group
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F I G U R E 1 hCG reverses CCI-induced
decreases in circulating testosterone and
progesterone. Plasma concentrations
(mean ± SEM) of T (A), P4 (B), 11-DOC (C)
and corticosterone (D) in ng/ml on PID
-10, 1, 11, 19 and 29 for the following
groups: Sham +vehicle (n = 5), Sham +hCG
(n = 5), CCI +saline (n = 8) and CCI +hCG
(n = 8). Data were analysed using 2-way
repeated-measures ANOVA; post hoc
analyses were performed using the Tukey
multiple comparison test (p < .05; letters
indicate differences between treatment
groups and pre- and post-injury days)
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F I G U R E 2 RU-486 treatment
attenuates hCG-induced reversal
of circulating testosterone plasma
concentrations. Plasma concentrations
(mean ± SEM) of T (A), P4 (B), 11-DOC (C)
and corticosterone (D) in ng/ml on PID
−10, 1, 11, 19 and 29 for the following
groups: RU-486: Sham +vehicle (n = 5),
RU-486: Sham +hCG (n = 5), RU-486: CCI
+saline (n = 5) and RU-486: CCI +hCG
(n = 5). Data were analysed using 2-way
repeated-measures ANOVA; post hoc
analyses were performed using the Tukey
multiple comparison test (p < .05; letters
indicate differences between treatment
groups and pre- and post-injury days).
Differences between RU-486-induced
changes in plasma hormones between
treatment groups in Figures 1 and 2 are
illustrated by (1) vertical lines represent an
increase in plasma hormone concentration
in RU-486-treated animals, and (2)
horizontal lines represent a decrease in
plasma hormone concentration in RU-
486-treated animals
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(4.5 ± 2.1 ng/ml) compared with the CCI +saline group (0.51 ± 0.2 ng/

(40.9 ± 10.0 ng/ml vs. 24.2 ± 5.8 ng/ml, p < .05), and suppressed T con-

ml, p < .03). hCG treatment transiently reduced circulating 11-DOC in

centrations on PID 11 (4.5 ± 1.5 ng/ml vs. 12.9 ± 4.3 ng/ml, p < .05) and

Sham surgery animals (123.1 ± 24.6 ng/ml) when compared to Sham

PID 19 (3.1 ± 1.1 ng/ml vs. 9.7 ± 1.4 ng/ml, p < .05; Figure 2A,B). RU-486

+saline animals (180.7 ± 3.3 ng/ml; p < .05) on PID 1, but not on PID

pretreatment had more significant effects on 11-DOC and corticoste-

11, 19 and 29 (Figure 1C). hCG treatment had no effect on increas-

rone, preventing the Sham + saline treatment-induced decrease in 11-

ing corticosterone concentrations in Sham animals at any time point,

DOC through PID 29 (Figure 2C) and preventing in Sham +hCG rats the

but did increase circulating corticosterone in the CCI animals on PID

decrease in 11-DOC at PID 1 (282.4 ± 28.0 ng/ml vs. 123.1 ± 24.6 ng/

1 and 11 (Figure 1D). Together, these results demonstrate that hCG

ml, p < .05). RU486 pretreatment prevented Sham surgery-induced

can reverse hypogonadism induced by a craniectomy or a craniec-

decreases in corticosterone through PID 29 in both saline- and hCG-

tomy +CCI injury, but has lesser effect on reversing hypoadrenalism.

treated animals (except on PID 19 in the Sham + hCG group; Figure 2D).
RU-486 pretreatment had no significant effects on circulating 11-DOC

3.3 | RU-486 diminishes craniectomy + CCI-
induced hypoadrenalism
ANOVA indicated a significant main effect of treatment for T
(F(3,71) = 3.76, p = .0145), P4 (F(3,61) = 5.82, p = .0011), 11-DOC

and corticosterone in CCI-injured animals (Figure 2C,D).

3.4 | Relationships between circulating steroid
concentrations before and after sham surgery, CCI
injury and hCG treatment

(F(3,61) = 3.66, p = .0171), and corticosterone (F(3,61) = 5.41,
p = .0023). A main effect of day was found for P4 (F(3,61) = 5.82,

Correlation analyses demonstrated strong positive correlations in

p = .0015) and corticosterone (F(3,61) = 3.38, p = .0238), but not

baseline plasma samples between P4 with androstenedione (r = .84,

for T (F(3,71) = 1.86, p = .145) or 11-DOC (F(3,61) = 1.80, p = .158).

p < .01), androstenedione with its metabolite T (r = .82, p < .01) and

No main effects of treatment × day interaction were found for T

with corticosterone and its precursor 11-DOC (r = .89, p < .001;

(F(9,71) = 0.33, p = .965), P4 (F(9,61) = 1.09, p = .3838), 11-DOC

Table 1). Sham injury obviated the significant correlations between

(F(9,61) = 0.54, p = .836) or corticosterone (F(9,61) = 0.65, p = .750).

sex steroids, but not corticosterone and its precursor 11-DOC

Pretreatment of animals with RU-486, a P4 receptor and gluco-

(r = 0.98, p < .001, Table 2). hCG treatment of Sham animals was suf-

corticoid receptor antagonist, had little effect on Sham +hCG ani-

ficient in restoring the strong positive relationship between T and

mals suppressing only P4 concentration on PID 29 (8.5 ± 4.5 ng/ml vs.

androstenedione (r = .76, p < .05), but not between P4 with andros-

31.8 ± 14.2 ng/ml, p < .05; compare Figures 1B and 2B). In CCI-injured

tenedione. hCG treatment induced two additional positive correla-

animals, RU-486 pretreatment increased P4 concentrations on PID 1

tions between androstenedione with 11-DOC (r = .84, p < .01) and

6 of 11
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androstenedione with corticosterone (r = .72, p < .05; Table 2). These

of memory in rodents53,54,56–58,60–63 and humans.35 Conversely, one

results suggest that Sham surgery alone is sufficient to disrupt the

study has demonstrated that intracerebroventricular hCG delivery

relationship between sex steroid metabolism, a relationship that is

after OVX rescued dendritic spine density and spatial memory.64

partially reversed with hCG treatment.

The general negative impact of LH/hCG on cognitive performance

CCI injury, like sham injury, resulted in positive relationships be-

appears to be dependent upon the ratio of gonadotropins to sex

tween P4 with corticosterone (r = .58, p < .01) and 11-DOC (r = .68,

steroids since situations where gonadotropins and sex steroids are

p < .001), between corticosterone and its precursor 11-DOC (r = .91,

in balance such as during the adult reproductive period65 are pe-

p < .001; Table 3), as well as the loss of significant correlations

riods of normal cognitive performance and do not involve dyotic

between sex steroids. Unlike sham injury, CCI injury resulted in a

signalling.32–34 This is illustrated by the findings that interventions

strong correlation between androstenedione with its metabolite T

that reverse dyotic signalling such as sex steroid supplementation

(r = .97, p < .001). Like Sham animals, hCG treatment of CCI animals

of ovariectomized animals (see references above), GnRH agonist

restored the positive relationship between T and androstenedione

suppression of gonadotropins in post-menopausal women35 and

(r = .64, p < .001), while the positive correlation between corticoste-

caloric restriction (eg Ref. 66), either reverse or halt cognitive de-

rone and 11-DOC (r = .93, p < .001) was maintained. Together, these

cline. Therefore, one might predict that functioning gonads are

results suggest that like Sham surgery, CCI injury disrupts sex ste-

essential for hCG to promote cognitive recovery from a TBI, as we

roid metabolism, while hCG treatment partially restores sex steroid

have found in intact male rats67 (unpublished data). Thus, hCG treat-

metabolism.

ment might be expected to be most beneficial in pre-menopausal
and pre-andropausal individuals, while those further along the post-

4

|

reproduction spectrum might benefit most from a combination ther-

DISCUSSION

apy of hCG supplemented with appropriate sex steroids.

We demonstrate for the first time that intraperitoneal injection of
hCG is effective in reversing hypogonadism (Figure 1A,B) and attenuating hypoadrenalism (Figure 1C,D) following a craniectomy or

4.1 | Causes of craniectomy and CCI injury induced
hypogonadism and hypoadrenalism

craniectomy +CCI injury in young adult male rats. Both craniectomy
and craniectomy +CCI injury promoted corticosteroid production

The induction of hypogonadism and hypoadrenalism in young male

in favour of sex steroid (P4) production, a relationship that was re-

rats following a craniectomy and a craniectomy +CCI injury (reduc-

versed with hCG treatment (Figure 1; Tables 1–3). hCG's ability to

tion in plasma concentrations of P4, T, 11-DOC and corticosterone;

increase sex steroid plasma concentrations following a craniectomy

Figure 1) is consistent with previous reports in rats.53,68 Since hCG

and following a moderate-to-severe brain injury supports its poten-

reversed hypogonadism and diminished hypoadrenalism in Sprague-

tial as a treatment for TBI-induced hypogonadism.

Dawley rats (Figures 1 and 2, Tables 1–3), our results suggest iso-

It is important to note that while hCG has potential to reverse hy-

flurane and/or surgical trauma/stress to the HP are impacting the

pogonadism and promote neurogenesis and cognitive recovery, an

long-term hypothalamic release of GnRH or the pituitary release of

increase in circulating hCG/LH concentrations as a result of ovariec-

gonadotropins rather than the production of steroids by the tes-

tomy53–58 or treatment59,60 has been shown to impair cognition in ro-

tes (or adrenals). Circulating cortisol concentrations are elevated

dents, while lowering LH or blocking LHCGR signalling is protective

following neurosurgical procedures in humans,69–71 but not during

TA B L E 1 The relationship between the concentrations of plasma steroids in rats
All groups and time points (PSD/PID 1, 11, 19 and 29)
T
Baseline samples
(PSD/PID -10)

T

P4

Androstenedione

11-DOC

Corticosterone

0.13
104

0.68***
92

0.22
104

0.15
104

0.28*
92

0.29*
104

0.25*
104

0.33**
92

0.19
108

P4

0.41
10

Androstenedione

0.82**
10

0.84**
10

11-DOC

0.40
10

−0.15
10

0.06
10

Corticosterone

0.27
10

−0.28
10

−0.11
10

0.90***
104
0.89***
10

Note: The top figure in each square is the coefficient of determination (r 2), and the bottom figure is the number of pairs that were analysed. The
results comprising the bottom left triangle are for rats at baseline and the top right triangle are for rats from all time points: post-surgery days (PSD)/
post-injury days (PID) 1, 11, 19 and 29 for all treatment groups (*p < .05, **p < .01, ***p < .001).
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TA B L E 2 The relationship between the concentrations of plasma steroids in Sham surgery rats treated with or without hCG
Sham + Saline (PSD 1, 11, 19 and 29)
T
Sham + hCG (PSD 1, 11,
19 and 29)

T

P4

Androstenedione

11-DOC

Corticosterone

0.29
20

0.04
20

<0.01
20

0.08
20

0.11
20

0.84***
20

0.87***
20

0.34
20

0.34
20

P4

0.05
20

Androstenedione

0.76*
20

0.29
14

11-DOC

0.44
20

0. 27
20

0.84**
14

Corticosterone

0.25
14

0.24
20

0.72*
14

0.98***
20
0.94***
20

Note: The top figure in each square is the coefficient of determination (r 2), and the bottom figure is the number of pairs that were analysed. The
results comprising the bottom left triangle are for Sham surgery rats treated with hCG and the top right triangle are for Sham surgery rats treated
with saline, from post-surgery days (PSD) 1, 11, 19 and 29 (*p < .05, **p < .01, ***p < .001).

TA B L E 3 The relationship between the concentrations of plasma steroids in CCI-injured rats treated with or without hCG
CCI + Saline (PID 1, 11, 19 and 29)
T
CCI + hCG
(PID 1, 11, 19 and 29)

T

P4

Androstenedione

11-DOC

Corticosterone

0.04
32

0.97***
32

−0.06
32

−0.10
32

0.08
32

0.67***
32

0.58**
32

−0.03
32

−0. 08
32

P4

0.27
32

Androstenedione

0.64***
32

0.30
32

11-DOC

0.26
32

0.30
32

0.20
32

Corticosterone

0.32
32

0.31
32

0.20
32

0.91***
32
0.93***
32

Note: The top figure in each square is the coefficient of determination (r 2), and the bottom figure is the number of pairs that were analysed. The
results comprising the bottom left triangle are for CCI injury rats treated with hCG and the top right triangle are for CCI injury rats treated with
saline, from post-injury days (PID) 1, 11, 19 and 29 (*p < .05, **p < .01, ***p < .001).

anaesthesia (nitrous oxide and halothane, after thiopentone induc-

hypogonadism and hypothyroidism.76,77 However, while our study

tion). Alternatively, or in conjunction, isoflurane anaesthesia admin-

implicates isoflurane in the induction of hypogonadism and hypo-

istered during the craniectomy may have inhibited hypothalamic

pituitarism via suppression of HP function, human studies suggest

and/or pituitary function since it has been reported that isoflurane

that TBI-induced hypogonadism and hypopituitarism is mediated

anaesthesia can dose-dependently suppress circulating follicle-

via suppression of HP function by elevated circulating cortisol.78,79

stimulating hormone and T concentrations, post-natal neurogenesis

Ranganathan et al.79 demonstrated that the stress of TBI results in

and cognitive performance in adult male Sprague-Dawley rats.72–75

anovulation and central hypothalamic-pituitary-ovarian axis sup-

Anaesthesia-induced hypogonadism and hypoadrenalism represents

pression, with menstruation resuming among pre-menopausal

another complication of anaesthesia that could impact the recovery

women when serum cortisol normalized to luteal phase control lev-

from and quality of life for those undergoing anaesthesia for a sur-

els. It is apparent that TBI-induced HH, even when limited to the

gical procedure. Further research is required to delineate whether

anterior hypothalamus,13,80 is a system problem commonly involv-

this effect is attributed to isoflurane on the functioning of the hypo-

ing both the HPG axis and the HPA axis.81 From our study, it is not

thalamus and/or pituitary, a combination of isoflurane and surgical

possible to determine whether the CCI injury had an impact beyond

stress or an effect of isoflurane early and of surgical stress later in

that of craniectomy on promoting hypogonadism or hypoadrenalism,

the maintenance of the hypogonadism over 29 days.

as has been reported for human TBI.6–8,10,14,76–78,82–96 These results

Our data are consistent with early studies in humans demon-

demonstrate that future studies need to take into account the ef-

strating that TBI could alter hypothalamic morphology and induce

fects of isoflurane alone in any model of TBI-induced hypogonadism.

8 of 11
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4.2 | hCG treatment for reversing hypopituitarism

adrenocorticotropic hormone that is observed in human men,107,108
women,108,109 and non-human primates (Macaca fascicularis110).

Our results in craniectomized and craniectomized plus CCI-injured

Blocking glucocorticoid and P4 signalling using RU-486 had little ef-

rats demonstrate that post-surgery and post-injury male rats retain

fect on sex steroid changes induced by craniectomy (uninjured) or

the capacity to synthesize and secrete T (Figure 1). The reversal of

CCI injury, but significantly diminished the decline in 11-DOC and

hypothalamic/pituitary function in animals induced by a TBI, craniec-

corticosterone concentrations in craniectomy (uninjured) but not

tomy and/or isoflurane anaesthesia indicates the utility of hCG for

CCI-injured animals (Figure 2A–D), indicating that blocking gluco-

reversing hypogonadism and hypoadrenalism in these conditions.

corticoid (and perhaps P4) receptor signalling partially prevents the

hCG treatment comes with the advantage of not only increasing

suppression of 11-DOC and corticosterone (either by limiting stress-

neurotropic hCG/LH, but also increasing the dozens of gonadal sex

induced suppression of 11-DOC/corticosterone or by elevating their

steroid and protein hormones that regulate normal brain structure

synthesis).

and function.32
hCG has been shown to increase T production in aged male
rats.97,98 hCG is a safe, cheap, FDA-approved treatment for hypogo-

5

|

LI M ITATI O N S O F TH E S T U DY

nadism in men (chronically), infertility in men and women, and to promote the descent of testicles in young boys with cryptorchidism.99 In

The suppression of circulating sex steroids by the Sham surgery

this context, hCG treatment has recently been shown to be effective

procedures was unexpected, and the “Sham CCI” group cannot be

in (1) raising plasma T concentrations in healthy men with chronic

considered a normal “Control” group in the usual sense of the term.

spinal cord injury, and this was not significantly different from hCG’s

Nonetheless, the fact that stress-induced HH can be reversed with

elevation of plasma T in able-bodied male control subjects,100 (2)

hCG administration is important from the perspective of a potential

protecting the rodent adult37,38 and neonatal brain from hypoxic-

treatment option for veterans returning from combat with stress- or

ischaemic cellular degeneration in vivo and inhibiting glutamate-

TBI-induced HH.6,14,45–47

40

dependent excitotoxic or necrotic neuronal cell death in vitro ; and
(3) increasing ERK phosphorylation, neurite outgrowth and rescuing

AC K N OW L E D G E M E N T S

ovariectomy-induced spatial memory deficits in C57Bl/6J mice.64 In

This study was funded by VA Merit Review grant #1I21RX001371

addition, hCG also partially attenuated hypoadrenalism in male rats.

(CSA). RIG was funded by the National Institute on Aging T32

Although there are few studies that have assessed the impact of

training grant #5T32AG00213. This material is the result of work

hCG on regulating adrenal steroid production, hCG has been demon-

supported with resources at the William S. Middleton Memorial

strated to increase follicular fluid concentrations of 11-DOC, but not

Veterans Hospital, Madison, WI. The opinions expressed herein

101

while LHβ overexpressing female mice have en-

are those of the authors. The contents do not represent the views

larged adrenals, increased LHCGR expression and a 14-fold elevation

corticosterone,

of the Department of Veterans Affairs or the U.S. government.

in serum corticosterone.102 In this latter study, the authors proposed

This article is Geriatrics Research, Education and Clinical Center

that enhanced ovarian oestrogen synthesis causes increased secre-

VA paper 005-2021. The Institute for Clinical and Translational

tion of prolactin, which elevates LHCGR expression in the mouse

Research, UW-Madison, NIH UL1T000427, provided support for

adrenal cortex, leading to elevated, LH-dependent, corticosterone

the steroid assays.

production.102 Continuous exposure to hCG is, however, known
to suppress the expression of LHCGR via the down-regulation of

C O N FL I C T O F I N T E R E S T

mRNA (eg Ref. 103,104). To circumvent the down-regulation of the

The authors declare that they have no competing interests.

receptor, in our study hCG was administered in the form of Pregnyl
every other day, as is used clinically.105 Since initial phase half-life

AU T H O R S ' C O N T R I B U T I O N S

of urinary-derived Pregnyl is between 5.6 and 11 h (https://www.

RIG, KH, RR, MW, QB, ADJ, IMA, GF and CSA performed surger-

merck.ca/), the 48 h between doses appears sufficient to maintain

ies, controlled cortical impact injuries and collected blood. AM and

LHCGR expression, as circulating concentrations of sex steroids

TEZ performed blood hormone analyses. RIG, SVM and CSA per-

(Figure 1A,B) were sustained over the 29-day experiment.

formed data and statistical analyses. CSA, SVM and RIG conceived
the study.

4.3 | RU-486 impact on plasma steroid
concentrations
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Elevations in circulating corticosterone observed in our study following RU-486 treatment are consistent with elevations in cor-
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